InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Holtzman Douglas, Directeur Scientifique. Director active across 1 companies, notably Icosavax, Inc.. In total, 3 filings have been logged. The latest transaction was filed on 10 February 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
019,485 shares0
Common Stock
SEC:0001209191-22-009513:0·
€523,41741,500 shares@ €12.6125100.0% of flow
Common Stock
SEC:0000899243-21-031147·
€523,41741,500 shares@ €12.612550.0% of flow
Common Stock
SEC:0000899243-21-031147:0·
3 of 3 declarations
About Holtzman Douglas
Douglas Holtzman is the Chief Scientific Officer of Icosavax, Inc. He is responsible for leading the company's research and development efforts, focusing on innovation in the biotechnology field. His role is crucial for the development of new therapies and for the strategic positioning of the company in the market.
